As of April 4, 2026, Icade SA's estimated intrinsic value ranges from $14.56 to $14.56 per share, depending on the valuation methodology applied.
| Valuation Method | Fair Value (USD) | Implied Upside/Downside |
|---|---|---|
| Discounted Cash Flow (5Y) | $14.56 | -27.4% |
Is Icade SA (ICAD.PA) undervalued or overvalued?
With the current market price at $20.04, the stock appears to be significantly overvalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Icade SA's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
| WACC Component | Low | High |
|---|---|---|
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.58 | 0.98 |
| Cost of equity | 6.4% | 10.6% |
| Cost of debt | 4.0% | 5.2% |
| Tax rate | 5.2% | 8.9% |
| Debt/Equity ratio | 2.84 | 2.84 |
| After-tax WACC | 4.5% | 6.3% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
| DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
|---|---|---|---|
| 5-Year Growth | $15 | $4,604M | 84.3% |
| 10-Year Growth | $(1,234) | $3,004M | 69.4% |
| 5-Year EBITDA | $(1,234) | $3,415M | 78.9% |
| 10-Year EBITDA | $(1,234) | $2,854M | 67.8% |
| Metric | Value |
|---|---|
| Market Capitalization | $1528M |
| Enterprise Value | $5022M |
| Trailing P/E | 0.00 |
| Forward P/E | 0.00 |
| Trailing EV/EBITDA | 18.30 |
| Current Dividend Yield | 2138.58% |
| Dividend Growth Rate (5Y) | 13.61% |
| Debt-to-Equity Ratio | 2.84 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
| Valuation Method | Weight | Weighted Value |
|---|---|---|
| Discounted Cash Flow (5Y) | 100% | $3.64 |
| Weighted Average | 100% | $14.56 |
Based on our comprehensive valuation analysis, Icade SA's intrinsic value is $14.56, which is approximately 27.4% below the current market price of $20.04.
Key investment considerations:
Given these factors, we believe Icade SA is currently significantly overvalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.